Bromotyrosine derivatives from marine sponges inhibit the HIV-1 replication in vitro

Background: Human immunodeficiency virus type 1 (HIV-1) infection and Acquired immunodeficiency syndrome are mayor global public health issues. HIV-1 infection is now manageable as a chronic disease thanks to the development of antiretroviral therapy; however, the existence of HIV drug resistance an...

Full description

Autores:
Gómez-Archila L.G.
Zapata Builes, Wildeman
Galeano E.
Martínez A.
Díaz F.J.
Rugeles M.T.
Tipo de recurso:
Article of journal
Fecha de publicación:
2014
Institución:
Universidad Cooperativa de Colombia
Repositorio:
Repositorio UCC
Idioma:
OAI Identifier:
oai:repository.ucc.edu.co:20.500.12494/42682
Acceso en línea:
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84905048823&partnerID=40&md5=1ff7fb8925ea131bb2b0ac75a7fb5606
https://hdl.handle.net/20.500.12494/42682
Palabra clave:
19 deoxyfistularin
3 bromo 5 hydroxy O methyl tyrosine
3 bromo N N N trimethyltyrosinium
3,5 dibromo N N N O tetramethyltyraminium
3,5 dibromo N N N trimethyltyraminium
3,5 dibromo N N N trimethyltyrosinium
aeroplysinin 1
bromotyrosine derivative
dihydroxyaerothionin
fistularin 3
purealidin b
tyrosine derivative
unclassified drug
zidovudine
Aiolochoria crassa
article
controlled study
cytotoxicity
dose response
flow cytometry
human
human cell
Human immunodeficiency virus 1 infection
MTT assay
nonhuman
polymerase chain reaction
reverse transcription
sponge (Porifera)
Verongula rigida
virus replication
Rights
closedAccess
License
http://purl.org/coar/access_right/c_14cb